House Energy & Commerce Committee
This article was originally published in The Gray Sheet
Executive SummaryOffice of the Independent Counsel attorney Keith Ausbrook will serve as counsel to Oversight & Investigations Subcommittee Chairman James Greenwood (R-Penn.), committee Chairman Billy Tauzin (R-La.) announces April 5. In addition, Raymond Shepherd, former legislative director for Rep. Fred Heineman (R-N.C.), has been tapped as an oversight counsel to the committee, Tauzin says
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.